logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

The comprehensive net asset value per share of INV(00721) at the end of March was approximately HKD 0.02.

date
16:56 13/04/2026
avatar
GMT Eight
China Financial International Limited (00721) announced that the unaudited net asset value per ordinary share as of March 31, 2026 was approximately 0.02 Hong Kong dollars.
C FIN INT INV (00721) announced that the unaudited net asset value per ordinary share as of March 31, 2026 is approximately 0.02 Hong Kong dollars.
Related Articles
HK Stock
SUNAC SERVICES (01516) spent 281,400 Hong Kong dollars to repurchase 300,000 shares on April 13th.
HK Stock
CHINA RES POWER(00836) The cumulative electricity sales volume of the first three months of the subsidiary power plants increased by 16.3% year-on-year.
HK Stock
NT PHARMA (01011): Lou Yongbin appointed as non-executive director.
SUNAC SERVICES (01516) spent 281,400 Hong Kong dollars to repurchase 300,000 shares on April 13th.
HK Stock
CHINA RES POWER(00836) The cumulative electricity sales volume of the first three months of the subsidiary power plants increased by 16.3% year-on-year.
HK Stock
NT PHARMA (01011): Lou Yongbin appointed as non-executive director.
HK Stock
RECOMMEND
Deloitte China Reports Three Mega Hong Kong IPOs Among Global Top Five In Q1
Deloitte China Reports Three Mega Hong Kong IPOs Among Global Top Five In Q1
icon
09/04/2026
Token Wave Reshapes China’s Internet Landscape
Token Wave Reshapes China’s Internet Landscape
icon
09/04/2026
State‑Owned Six Banks Saw Consumer Loan Balances Rise Over RMB 55 Billion Last Year, Five Banks Grew Above 16% — Will The Surge Continue In 2026?
State‑Owned Six Banks Saw Consumer Loan Balances Rise Over RMB 55 Billion Last Year, Five Banks Grew Above 16% — Will The Surge Continue In 2026?
icon
09/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.